Overview

Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion.

Status:
ENROLLING_BY_INVITATION

Trial end date:
2026-12-30

Target enrollment:

Participant gender:

Summary

Efficacy and safety evaluation of PLB1004 in patients with locally advanced/metastatic non-squamous NSCLCharboring EGFR exon 20 insertion.

Phase:

PHASE3

Details

Lead Sponsor:

Avistone Biotechnology Co., Ltd.